Please login to the form below

Not currently logged in
Email:
Password:

Research Partnership appoints three new office heads

Expands on US west coast and in Boston

Research_Partnership_Christine_NaegleHealthcare market research firm the Research Partnership has appointed three new office heads for as it expands its operations on the west coast of the US and in Boston.

Both Christine Naegle and Birgit Eschmann join from GfK Healthcare and respectively will head up the newly established LA office and the San Francisco office.

Naegle (pictured right) spent more than 20 years at GfK serving in a variety of market research roles, working in both qualitative and quantitative research across anti-infectives, oncology, ophthalmology and medical devices.

Her most recent position was senior VP, group key account manager.

Research_Partnership_Birgit_EschmannEschmann (pictured left) was assistant VP research and consulting at GfK and has a broad experience across a range of therapy areas and has particular expertise in oncology, medical devices and infectious diseases.

The Research Partnership also announced it had established a new office in Boston, which is to be headed by Claire Richardson, who joined the company as a director in October 2012.

Mary Assimakopoulos, founding director of the Research Partnership, said: “We are delighted to make this announcement, which demonstrates the company's continued investment in our US capabilities. Our offices in Philadelphia, Boston, LA and San Francisco will allow us to fully service the US domestic and global market and continue to expand our growing customer base.”

2nd May 2013

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Blue Latitude Health

Blue Latitude Health is a creative marketing consultancy. Founded in 2003, our combination of heritage, approach and capability gives us...

Latest intelligence

Enabling market access through outcomes-based pricing
Outcomes-based pricing is a potential solution to create a link between product price and real-world outcomes, while at the same time facilitating patient access to new and innovative medicines....
Five companies 20 for 2020
20 for 2020 – Five pharma companies to watch
As a new decade gets into gear, we take a look at five pharma companies that have a lot riding on 2020...
The growing clinical importance of patient-reported outcomes (PROs)
Traditionally, the success or otherwise of medical treatments has been assessed by mortality or clinical assessments of health. However, patient self-reports of health are increasingly seen as central to the...

Infographics